We are live on ! Find out more
SBL

Sargent Bickham Lagudis Portfolio holdings

AUM $1.22B
1-Year Est. Return 14.94%
This Fund
S&P 500
This Quarter Est. Return
-5.19%
1 Year Est. Return
-14.94%
3 Year Est. Return
+19.11%
5 Year Est. Return
+40.37%
10 Year Est. Return
AUM
$1.12B
AUM Growth
-$38.6M
Cap. Flow
+$28.7M
Cap. Flow %
2.56%
Top 10 Hldgs %
39.83%
Holding
1,171
New
71
Increased
204
Reduced
288
Closed
154

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.58%
3 Financials 4.86%
4 Consumer Discretionary 3.63%
5 Consumer Staples 2.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLK
1151
DELISTED
Splunk Inc
SPLK
-11
Closed -$1K
ABCM
1152
DELISTED
Abcam PLC
ABCM
-120
Closed -$2K
VRTV
1153
DELISTED
VERITIV CORPORATION
VRTV
$0 ﹤0.01%
1
RAD
1154
DELISTED
Rite Aid Corporation
RAD
$0 ﹤0.01%
15
CELL
1155
DELISTED
PhenomeX Inc. Common Stock
CELL
$0 ﹤0.01%
50
MMP
1156
DELISTED
Magellan Midstream Partners, L.P.
MMP
-577
Closed -$28K
ARNC
1157
DELISTED
Arconic Corporation
ARNC
$0 ﹤0.01%
+10
New +$259
AMRS
1158
DELISTED
Amyris Inc.
AMRS
$0 ﹤0.01%
23
-4
-15% -$11
UNVR
1159
DELISTED
Univar Solutions Inc.
UNVR
-21
Closed -$1K
LSI
1160
DELISTED
Life Storage, Inc.
LSI
-5
Closed -$1K
LYLT
1161
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$0 ﹤0.01%
16
TMDI
1162
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$0 ﹤0.01%
30
CVET
1163
DELISTED
Covetrus, Inc. Common Stock
CVET
$0 ﹤0.01%
17
-194
-92% -$4.04K
TMX
1164
DELISTED
Terminix Global Holdings, Inc.
TMX
-2,400
Closed -$98K
PSY
1165
DELISTED
Defiance Next Gen Altered Experience ETF
PSY
-20
Closed
EMBK
1166
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$0 ﹤0.01%
25
EPZM
1167
DELISTED
Epizyme, Inc
EPZM
-500
Closed -$1K
SAFM
1168
DELISTED
Sanderson Farms Inc
SAFM
-148
Closed -$32K
HZNP
1169
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-41
Closed -$3K
SIVB
1170
DELISTED
SVB Financial Group
SIVB
-10
Closed -$4K
VSTO
1171
DELISTED
Vista Outdoor Inc.
VSTO
-17
Closed

Similar funds

Sargent Bickham Lagudis's Q3 2022 Portfolio in Review

As of Q3 2022, Sargent Bickham Lagudis held 1,171 positions worth $1.12B, down 3.3% from $1.16B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sargent Bickham Lagudis's Q3 2022 filing shows 71 new, 204 increased, 288 reduced and 154 closed positions. Its largest new stake was iShares iBonds Dec 2023 Term Treasury ETF: 4,978 shares worth $123K. The largest sale was Vanguard Extended Market ETF, an estimated $12.5M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 5.9% a quarter earlier, followed by Healthcare and Financials.

  • Sargent Bickham Lagudis's largest Q3 2022 buy was iShares iBonds Dec 2023 Term Treasury ETF: 4,978 shares worth $123K.
  • Sargent Bickham Lagudis added most to Vanguard Russell 2000 ETF in Q3 2022, an estimated $28M increase.
  • Sargent Bickham Lagudis's biggest Q3 2022 reduction was Vanguard Extended Market ETF, cutting an estimated $12.5M.
  • Sargent Bickham Lagudis fully exited Transmedics in Q3 2022, selling an estimated $138K.
  • Sargent Bickham Lagudis's ten largest holdings make up 40% of its $1.12B portfolio in Q3 2022.
  • Sargent Bickham Lagudis opened 71 new positions and closed 154 in Q3 2022.
  • Sargent Bickham Lagudis's portfolio value fell 3.3% quarter-over-quarter to $1.12B.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2022, filed 27 Oct 2022.